longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Orchestra BioMed(OBIO.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Orchestra BioMed (NASDAQ:OBIO) Given New $10.00 Price Target at B. Riley Financial

Market Beat·Yesterday at 03:54
US
OBIO
+0.50%
US
SBIO
-1.24%
US
PBE
+0.11%
Market Beat·Yesterday at 03:54
US
OBIO
+0.50%
US
SBIO
-1.24%
US
PBE
+0.11%

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates | OBIO Stock News

StockTitan·05/12/2026 20:20
US
OBIO
+0.50%
US
PBE
+0.11%
US
LABU
-2.35%
StockTitan·05/12/2026 20:20
US
OBIO
+0.50%
US
PBE
+0.11%
US
LABU
-2.35%

Orchestra Gains on $20M Buy-in from Medtronic

Baystreet·05/06/2026 21:37
US
OBIO
+0.50%
US
MDT
+1.63%
US
BIB
+0.05%
Baystreet·05/06/2026 21:37
US
OBIO
+0.50%
US
MDT
+1.63%
US
BIB
+0.05%

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 | OBIO Stock News

StockTitan·04/23/2026 16:01
US
OBIO
+0.50%
US
LABU
-2.35%
US
SBIO
-1.24%
StockTitan·04/23/2026 16:01
US
OBIO
+0.50%
US
LABU
-2.35%
US
SBIO
-1.24%
© 2026 Longbridge|Disclaimer

Event Tracking

May13
Orchestra BioMed released FY2026 Q1 earnings on May 12 (EST), actual revenue USD 110 K (forecast USD 160.83 K), actual EPS USD -0.3304 (forecast USD -0.434)
03:00
Mar13
Orchestra BioMed released FY2025 Annual Earnings on March 12 (EST), Actual Revenue USD 33.48 M (Forecast USD 3.467 M), Actual EPS USD -1.109 (Forecast USD -1.7383)
03:00
Orchestra BioMed released FY2025 Q4 earnings on March 12 (EST), actual revenue USD 30.92 M (forecast USD 925.29 K), actual EPS USD 0.0959 (forecast USD -0.3783)
03:00
Jan12
Orchestra BioMed to Gain $21 Million from Sale of Vivasure Medical
14:00
Jan9
Orchestra Biomed Outlines Progress in Hypertension and Arterial Disease Therapies
22:36
Dec8
Orchestra BioMed showcases AVIM therapy and Virtue SAB with Medtronic for hypertension treatment
12:00

Schedules & Filings

Schedules
Filings
May12
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 110 K, Net Income -20.73 M, EPS -0.3304

Mar12
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 30.92 M, Net Income 5.991 M, EPS 0.0966

Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 861 K, Net Income -20.83 M, EPS -0.3991

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INM
1.600
+135.05%
+0.919
AMPGZ
0.5800
+132.00%
+0.330
AMST
1.730
+120.07%
+0.944
CNEY
1.610
+119.77%
+0.877
AMPGR
0.5000
+102.02%
+0.253
NXXT
0.8201
+100.02%
+0.410
WNW
4.750
+97.10%
+2.340
GIPR
0.4290
+75.89%
+0.185
MTVA
1.880
+69.37%
+0.770
SVRN
8.200
+49.64%
+2.720
View More